Bioterrorism: The Centers for Disease Control and Prevention's Role in Public Health Protection, Statement for the Record by Janet Heinrich, Director, Health Care--Public Health Issues, Testimony before the Committee on Energy and Commerce, House of Representatives [open pdf - 135KB]
CDC has a variety of ongoing research and preparedness activities related to bioterrorism. Most of CDC's activities to counter bioterrorism are focused on building and expanding public health infrastructure at the federal, state, and local levels. These include funding research on anthrax and smallpox vaccines, increasing laboratory capacity, and building a national pharmaceutical stockpile of drugs and supplies to be used in an emergency. Since CDC's bioterrorism program began in 1999, funding increased 43 percent in fiscal year 2000 and an additional 12 percent in fiscal year 2001. While the percentage increases are substantial, they reflect only a $73 million increase in overall spending because many of the activities initially received relatively small allocations. Gaps in CDC's activities could hamper the response to a bioterrorist attack. For instance, laboratories at all levels can quickly become overwhelmed with requests for tests. In addition, there is a notable lack of training focused on detecting and responding to bioterrorist threats.
Government Accountability Office (GAO): http://www.gao.gov/